Navigation

  • Skip to Content
NTNU Home NTNU Home

ntnu.edu

  • Studies
    • Master's programmes in English
    • For exchange students
    • PhD opportunities
    • All programmes of study
    • Courses
    • Financing
    • Language requirements
    • Application process
    • Academic calendar
    • FAQ
  • Research and innovation
    • NTNU research
    • Research excellence
    • Strategic research areas
    • Innovation resources
    • PhD opportunities
  • Life and housing
    • Student in Trondheim
    • Student in Gjøvik
    • Student in Ålesund
    • For researchers
    • Life and housing
  • About NTNU
    • Contact us
    • Faculties and departments
    • Libraries
    • International researcher support
    • Vacancies
    • About NTNU
    • Maps
  1. Employees

Språkvelger

Norsk

Magne Børset

Download press photo
Download press photo
Foto:

Magne Børset

Professor
Department of Clinical and Molecular Medicine

magne.borset@ntnu.no
+4791194488 +4772573038 Gastrosenteret, 433.03.008, Øya, Prinsesse Kristinas gate 1
Scopus Author ID: 7004270092
About Publications

About

CV

 

Mini-CV

  • M.D. 1988
  • Ph.D. 1996
  • Specialist in clinical immunology and transfusion medicine

Current positions

  • Professor of cell biology and hematological cancer, NTNU
  • Senior Consultant, Dept. of Immunology and Transfusion Medicine, St. Olavs Hospital

 

Research highlights in the study of multiple myeloma (MM):

  • 1993: Description of a new separation method for MM cells based on antibodies against syndecan-1 (CD138).
  • 1994: Establishment of OH-2, an IL-6- and TNF-dependent MM cell line that has since been shown to be a unique hyperdiploid cell line without IgH translocations.
  • 1996: The first publication ever on NF-kappa-B activation in human MM cells
  • 1996: First publications on expression of hepatocyte growth factor (HGF) and autocrine stimulation of the HGF receptor c-Met in MM cells.
  • 1996: Elevation of HGF in serum from patients with MM compared to healthy controls
  • 1998: Serum HGF concentration is a prognostic factor for patients with MM and is reduced after response to treatment.
  • 1999: Description of a dual role of Fas in myeloma cells; induction of both apoptosis and proliferative responses.
  • 1999: HGF induces production of the osteoclast-stimulating cytokine IL-11 in osteoblastic cells.
  • 1999: First paper showing proliferation of myeloma cells induced by IL-15 and production of IL-15 mRNA in MM cells.
  • 1999: Establishment of a mouse model for MM showing depletion of osteoblasts from affected skeletal tissue.
  • 2000: First paper on prognostic impact of serum level of syndecan-1 in patients with MM
  • 2000: Polarization of syndecan-1 and heparin-binding molecules on the surface of MM cells
  • 2000: High levels of syndecan-1 in MM bone marrow modulate the activity of HGF.
  • 2000: First paper on expression of urokinase plasminogen activator (uPA) and the aPA receptor in MM cells.
  • 2001: Bone morphogenetic protein-4 (BMP-4) induces apoptosis in MM cells.
  • 2001: First paper showing reduced levels of osteoprotegerin (OPG) in serum from patients with MM
  • 2002: First paper on proliferative effect of IL-21 on MM cells.
  • 2002: Serum IGF-1 is not elevated in MM patients, but is still a prognostic factor
  • 2002: OPG is bound and internalized by MM cells.
  • 2004: BMP-5, -6 and -7 induce apoptosis in MM cells.
  • 2004: Osteopontin is an adhesive factor for MM cells and is increased in serum from patients with MM
  • 2005: An inhibitor of HGF receptor c-Met blocks autocrine growth of MM cells.
  • 2005: HGF induces adhesion of MM cells to fibronectin
  • 2006: First paper showing that toll-like receptors mediate proliferation of MM cells.
  • 2007: HGF inhibits BMP-induced osteoclastogensis.
  • 2008: Metastasis-associated phosphatase PRL-3 is expressed in malignant but not in healthy plasma cells.
  • 2008: HGF promotes migration of MM cells
  • 2008: Elevated serum levels of HGF activator in patients with MM
  • 2010: Myeloma cell line OH-2 is hyperdiploid and represents a subgroup of myeloma cases that are frequent but rarely give rise to cell lines.
  • 2011: The kinase SGK-1 is expressed in myeloma cells where it promotes cell growth.
  • 2012: BMPs induce apoptosis of myeloma cells by repressing MYC.
  • 2013: Anti-c-Met nanobodies as potential myeloma drug.
  • 2013: Synergy between HGF, IGF-1 and SGK-1 in promoting myeloma cell growth.
  • 2016: PRL-3 is important for IL-6-mediated survival of myeloma cells.
  • 2017: Src Family Kinases Are Regulated in Multiple Myeloma Cells by PRL-3
  • 2017: First papers showing that PRL-3 is overexpressed in prostate cancer cells and is associated with an unfavorable prognosis
  • 2018: PRL-3 is expressed and is important for migration in B cell lymphoblastic leukemia and Hodgkin lymphoma
  • 2020: Myeloma converts ATP to immunosuppressive adenosine by the enzymes CD39 and CD73. Immunosuppression can be reverted by blocking CD39 and adenosine receptors. 
  • 2021: Inhibitors of PHGDH, an enzyme in the serine synthesis pathway, can induce death of myeloma cells both in vitro and in vivo.
  • 2021: PRL-3 stimulates aerobic glycolysis in myeloma cells.
  • 2021: PRL-3 acts primarily as a pseudophosphatase.

Publications

  • Chronological
  • By category
  • See all publications in Cristin

2016

  • Våtsveen, Thea Kristin; Børset, Magne; Dikic, Aida; Tian, Erming; Micci, Francesca; Lid, Ana Barragan. (2016) VOLIN and KJON—Two novel hyperdiploid myeloma cell lines. Genes, Chromosomes and Cancer
    Academic article
  • Abdollahi, Pegah; Vandsemb, Esten Nymoen; Hjort, Magnus Aassved; Misund, Kristine; Holien, Toril; Sponaas, Anne-Marit. (2016) Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3. Molecular Cancer Research
    Academic article
  • Slørdahl, Tobias Schmidt; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Rampa, Christoph Samuel; Misund, Kristine; Baranowska, Katarzyna Anna. (2016) The phosphatase of regenerating liver-3 (PRL-3) is importantfor IL-6-mediated survival of myeloma cells. OncoTarget
    Academic article

2013

  • Slørdahl, Tobias Schmidt; Denayer, Tinneke; Moen, Siv Helen; Standal, Therese; Børset, Magne; Ververken, Cedric. (2013) Anti-c-MET Nanobody® – a new potential drug in multiple myeloma treatment. European Journal of Haematology
    Academic article
  • Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders. (2013) HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology
    Academic article

2012

  • Holien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Rampa, Christoph Samuel; Brede, Gaute; Grøseth, Lill Anny Gunnes. (2012) Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia
    Academic article
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders. (2012) Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology
    Academic article

2011

  • Skliris, A; Happonen, KE; Terpos, Evangelos; Labropoulou, V; Børset, Magne; Heinegård, Dick. (2011) Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma. European Journal of Immunology
    Academic article
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders. (2011) Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology
    Academic article
  • Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne. (2011) Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene
    Academic article

2009

  • Vatsveen, TK; Våtsveen, Thea Kristin; Tian, Erming; Kresse, Stine H; Meza-Zepada, Leonardo; Meza, Leonardo Zepeda. (2009) OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus. Leukemia Research
    Academic article
  • Våtsveen, Thea Kristin; Brenne, Anne-Tove; Dai, HY; Waage, Anders; Sundan, Anders; Børset, Magne. (2009) FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14). European Journal of Haematology
    Academic article

2008

  • Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Thea Kristin; Zhan, FH; Egeberg, Kjartan Wøllo. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
    Academic literature review

2007

  • Holt, RU; Fagerli, UM; Ro, TB; Baykov, V; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
    Abstract

2006

  • Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne. (2006) HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood
    Abstract
  • Bohnhorst, Janne Øvrebø; Rasmussen, T; Moen, Siv H; Fløttum, Marianne; Knudsen, L; Børset, Magne. (2006) Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia
    Academic article

2005

  • Holt, Randi Utne; Baykov, Vadim; Rø, Torstein Baade; Brabrand, Sigmund; Waage, Anders; Sundan, Anders. (2005) Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor. Haematologica
    Academic article

2004

  • Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
    Academic article
  • Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. (2004) Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene
    Academic article

2002

  • Standal, Therese; Børset, Magne; Lenhoff, S.; Wisløff, Finn; Størdal, Berit Fladval; Sundan, Anders. (2002) Serum insulin-like growth factor is not increased in patients with multiple myelomna but is still a prognostic factor. Blood
    Academic article
  • Brenne, Anne Tove; Rø, Torstein Baade; Waage, Anders; Sundan, Anders; Børset, Magne; Hjorth-Hansen, Henrik. (2002) Interleukin-21 is a growth and survival factor for human myeloma cells. Blood
    Academic article

2001

  • Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan. (2001) Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood
    Academic article
  • Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood
    Academic article
  • Feuerherm, Astrid; Børset, Magne; Seidel, Carina; Sundan, Anders; Leistad, Lilian; Østensen, Monica. (2001) Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scandinavian Journal of Rheumatology
    Academic article

2000

  • Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D.. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood
    Academic article
  • Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik. (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood
    Academic article
  • Seidel, Carina; Sundan, Anders; Hjorth, Martin; Turesson, Ingemar; Dahl, Inger Marie S.; Abildgaard, Niels. (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood
    Academic article

1999

  • Børset, Magne; Hjort-Hansen, Henrik; Johnsen, Ann-Charlotte; Seidel, Carina; Waage, Anders; Espevik, Terje. (1999) Apoptosis, proliferation and NF-k(kappa)B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. European Journal of Haematology
    Academic article
  • Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood
    Academic article
  • Hjort-Hansen, Henrik; Waage, Anders; Børset, M.. (1999) Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. British Journal of Haematology
    Academic article
  • Hjorth-Hansen, H.; Seifert, MF.; Børset, M.; Aarset, H.; Ostlie, A.; Sundan, A.. (1999) Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. Journal of Bone and Mineral Research
    Academic article

1998

  • Seidel, C; Børset, M; Turesson, I; Abilgaard, N; Sundan, A.; Waage, Anders. (1998) Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood
    Academic article

1996

  • Børset, Magne; Medvedev, Andrei E.; Sundan, Anders; Espevik, Terje. (1996) The role of the two TNF receptors in proliferation, NF-_KB activation and discrimination between TNF and LT_a signalling in the human myeloma cell line OH-2. Cytokine
    Academic article
  • Børset, Magne; Lien, Egil; Espevik, Terje; Helseth, Eirik; Waage, Anders; Sundan, Anders. (1996) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. Journal of Biological Chemistry
    Academic article
  • Børset, Magne; Hjorth-Hansen, Henrik; Seidel, Carina; Sundan, Anders; Waage, Anders. (1996) Hepatocyte growth factor and its receptor c-MET in multiple myeloma. Blood
    Academic article

Journal publications

  • Våtsveen, Thea Kristin; Børset, Magne; Dikic, Aida; Tian, Erming; Micci, Francesca; Lid, Ana Barragan. (2016) VOLIN and KJON—Two novel hyperdiploid myeloma cell lines. Genes, Chromosomes and Cancer
    Academic article
  • Abdollahi, Pegah; Vandsemb, Esten Nymoen; Hjort, Magnus Aassved; Misund, Kristine; Holien, Toril; Sponaas, Anne-Marit. (2016) Src family kinases are regulated in multiple myeloma cells by phosphatase of regenerating liver-3. Molecular Cancer Research
    Academic article
  • Slørdahl, Tobias Schmidt; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Rampa, Christoph Samuel; Misund, Kristine; Baranowska, Katarzyna Anna. (2016) The phosphatase of regenerating liver-3 (PRL-3) is importantfor IL-6-mediated survival of myeloma cells. OncoTarget
    Academic article
  • Slørdahl, Tobias Schmidt; Denayer, Tinneke; Moen, Siv Helen; Standal, Therese; Børset, Magne; Ververken, Cedric. (2013) Anti-c-MET Nanobody® – a new potential drug in multiple myeloma treatment. European Journal of Haematology
    Academic article
  • Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders. (2013) HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology
    Academic article
  • Holien, Toril; Våtsveen, Thea Kristin; Hella, Hanne; Rampa, Christoph Samuel; Brede, Gaute; Grøseth, Lill Anny Gunnes. (2012) Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia
    Academic article
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders. (2012) Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology
    Academic article
  • Skliris, A; Happonen, KE; Terpos, Evangelos; Labropoulou, V; Børset, Magne; Heinegård, Dick. (2011) Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma. European Journal of Immunology
    Academic article
  • Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders. (2011) Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology
    Academic article
  • Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne. (2011) Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene
    Academic article
  • Vatsveen, TK; Våtsveen, Thea Kristin; Tian, Erming; Kresse, Stine H; Meza-Zepada, Leonardo; Meza, Leonardo Zepeda. (2009) OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus. Leukemia Research
    Academic article
  • Våtsveen, Thea Kristin; Brenne, Anne-Tove; Dai, HY; Waage, Anders; Sundan, Anders; Børset, Magne. (2009) FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14). European Journal of Haematology
    Academic article
  • Fagerli, Unn-Merete; Holt, Randi Utne; Holien, Toril; Våtsveen, Thea Kristin; Zhan, FH; Egeberg, Kjartan Wøllo. (2008) Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells. Blood
    Academic literature review
  • Holt, RU; Fagerli, UM; Ro, TB; Baykov, V; Waage, Anders; Sundan, Anders. (2007) HGF promotes migration of myeloma cells. Haematologica
    Abstract
  • Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne. (2006) HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood
    Abstract
  • Bohnhorst, Janne Øvrebø; Rasmussen, T; Moen, Siv H; Fløttum, Marianne; Knudsen, L; Børset, Magne. (2006) Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia
    Academic article
  • Holt, Randi Utne; Baykov, Vadim; Rø, Torstein Baade; Brabrand, Sigmund; Waage, Anders; Sundan, Anders. (2005) Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor. Haematologica
    Academic article
  • Hov, Håkon; Holt, Randi Utne; Rø, Torstein Baade; Fagerli, Unn-Merete; Hjort-Hansen, Henrik; Baykov, Vadim. (2004) A Selective c-Met Inhibitor Blocks an Autocrine Hepatocyte Growth Factor Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma cells. Clinical Cancer Research
    Academic article
  • Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. (2004) Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene
    Academic article
  • Standal, Therese; Børset, Magne; Lenhoff, S.; Wisløff, Finn; Størdal, Berit Fladval; Sundan, Anders. (2002) Serum insulin-like growth factor is not increased in patients with multiple myelomna but is still a prognostic factor. Blood
    Academic article
  • Brenne, Anne Tove; Rø, Torstein Baade; Waage, Anders; Sundan, Anders; Børset, Magne; Hjorth-Hansen, Henrik. (2002) Interleukin-21 is a growth and survival factor for human myeloma cells. Blood
    Academic article
  • Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan. (2001) Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood
    Academic article
  • Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood
    Academic article
  • Feuerherm, Astrid; Børset, Magne; Seidel, Carina; Sundan, Anders; Leistad, Lilian; Østensen, Monica. (2001) Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scandinavian Journal of Rheumatology
    Academic article
  • Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D.. (2000) Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood
    Academic article
  • Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik. (2000) High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood
    Academic article
  • Seidel, Carina; Sundan, Anders; Hjorth, Martin; Turesson, Ingemar; Dahl, Inger Marie S.; Abildgaard, Niels. (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood
    Academic article
  • Børset, Magne; Hjort-Hansen, Henrik; Johnsen, Ann-Charlotte; Seidel, Carina; Waage, Anders; Espevik, Terje. (1999) Apoptosis, proliferation and NF-k(kappa)B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor. European Journal of Haematology
    Academic article
  • Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne. (1999) Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood
    Academic article
  • Hjort-Hansen, Henrik; Waage, Anders; Børset, M.. (1999) Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. British Journal of Haematology
    Academic article
  • Hjorth-Hansen, H.; Seifert, MF.; Børset, M.; Aarset, H.; Ostlie, A.; Sundan, A.. (1999) Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. Journal of Bone and Mineral Research
    Academic article
  • Seidel, C; Børset, M; Turesson, I; Abilgaard, N; Sundan, A.; Waage, Anders. (1998) Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood
    Academic article
  • Børset, Magne; Medvedev, Andrei E.; Sundan, Anders; Espevik, Terje. (1996) The role of the two TNF receptors in proliferation, NF-_KB activation and discrimination between TNF and LT_a signalling in the human myeloma cell line OH-2. Cytokine
    Academic article
  • Børset, Magne; Lien, Egil; Espevik, Terje; Helseth, Eirik; Waage, Anders; Sundan, Anders. (1996) Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. Journal of Biological Chemistry
    Academic article
  • Børset, Magne; Hjorth-Hansen, Henrik; Seidel, Carina; Sundan, Anders; Waage, Anders. (1996) Hepatocyte growth factor and its receptor c-MET in multiple myeloma. Blood
    Academic article

NTNU – Norwegian University of Science and Technology

  • For employees
  • |
  • For students
  • |
  • Intranet
  • |
  • Blackboard

Studies

  • Master's programmes in English
  • For exchange students
  • PhD opportunities
  • Courses
  • Career development
  • Continuing education
  • Application process

News

  • NTNU News
  • Vacancies

About NTNU

  • About the university
  • Libraries
  • NTNU's strategy
  • Research excellence
  • Strategic research areas
  • Organizational chart

Contact

  • Contact NTNU
  • Employees
  • Find experts
  • Press contacts
  • Researcher support
  • Maps

NTNU in three cities

  • NTNU in Gjøvik
  • NTNU in Trondheim
  • NTNU in Ålesund

About this website

  • Use of cookies
  • Accessibility statement
  • Privacy policy
  • Editorial responsibility
Facebook Instagram Linkedin Snapchat Tiktok Youtube
Sign In
NTNU logo